Own the commercial marketing strategy for a CAR-T portfolio across current and future autoimmune indications, including launch planning, positioning, and lifecycle expansion.
Partner closely with Sales, Medical Affairs, Market Access, and senior leadership to translate clinical insights into differentiated omnichannel strategies for HCPs and patients.
Build and lead a high-performing marketing organization, establishing capabilities, infrastructure, and repeatable launch models for subsequent indications and products.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. As a growth-stage biotech, the company emphasizes core values such as collaboration, clarity, innovation, and ownership, fostering a fast-paced and entrepreneurial culture.
Own the end-to-end marketing and communications strategy to bring the first longevity drug for dogs to market.
Build a new category of medicine with both veterinary professionals and consumers as key audiences.
Evolve from category-building to team building and launch preparation as we approach FDA approval.
Loyal is a clinical-stage veterinary medicine company developing longevity drugs for dogs. It is a well-funded startup with teams of scientists, veterinarians, engineers, operators, and creatives.
Lead product launches, campaigns, and marketing projects end to end across Eastern Europe distributor markets.
Manage senior distributor relationships and translate regional direction into effective market activity.
Partner with cross-functional teams and the Marketing Coordinator to deliver priority projects and measure success.
Dexcom Corporation is a pioneer and global leader in continuous glucose monitoring (CGM), developing biosensing technology to empower people to take control of health. The company is driven by thousands of ambitious, passionate people worldwide committed to improving human health.